title: [Angiogenesis and bladder cancer: trendy prognostic factor or new therapeutic target?].
abstract: Tumor-associated angiogenesis is emerging as an important prognostic factor and represents a hopeful potential therapeutic target for the cancer treatment. Bladder tumors, as all solid tumors, require an active angiogenesis to support their growth and progression. The angiogenic phenotype observed within a tumor is determined in large part by the balance between stimulatory and inhibitory inputs to the endothelial cells. Clinically, the importance of the angiogenic response observed within a tumor should be considered as an independent prognostic factor for superficial as well as invasive bladder tumors. The analysis of the angiogenic response could in the future influence the therapeutic strategy. Angiogenesis also represents a promising new therapeutic target, and is at the moment intensively tested in experimental and clinical trials. In this article, we will first review the mechanism of angiogenesis, and then its implication in bladder cancer, and as a potential therapeutic target.
authors.affiliation: Service d'urologie, centre hospitalier universitaire Vaudois, 1011 Lausanne, Suisse. cjayet@hotmail.com
authors.forename: C
authors.initials: C
authors.lastname: Jayet
authors.forename: D
authors.initials: D
authors.lastname: Deperthes
authors.forename: H J
authors.initials: HJ
authors.lastname: Leisinger
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000037:antagonists & inhibitors / Q000502:physiology; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000503:physiopathology; D002986:Clinical Trials as Topic; D003094:Collagen / Q000627:therapeutic use*; D043169:Endostatins; D016222:Fibroblast Growth Factor 2 / Q000037:antagonists & inhibitors; D006801:Humans; D008207:Lymphatic Metastasis; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D010446:Peptide Fragments / Q000627:therapeutic use*; D010641:Phenotype; D011379:Prognosis; D011817:Rabbits; D012106:Research; D012189:Retrospective Studies; D012307:Risk Factors; D019700:Thrombospondin 1 / Q000502:physiology; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000401:mortality / Q000503:physiopathology
chemical_list: D043925:Angiogenesis Inducing Agents; D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D043169:Endostatins; D010446:Peptide Fragments; D019700:Thrombospondin 1; D016222:Fibroblast Growth Factor 2; D003094:Collagen